Literature DB >> 29582176

Hypoglycemia Prevention by Algorithm Design During Intravenous Insulin Infusion.

Susan Shapiro Braithwaite1,2, Lisa P Clark3, Thaer Idrees4, Faisal Qureshi5, Oluwakemi T Soetan4.   

Abstract

PURPOSE OF REVIEW: This review examines algorithm design features that may reduce risk for hypoglycemia while preserving glycemic control during intravenous insulin infusion. We focus principally upon algorithms in which the assignment of the insulin infusion rate (IR) depends upon maintenance rate of insulin infusion (MR) or a multiplier. RECENT
FINDINGS: Design features that may mitigate risk for hypoglycemia include use of a mid-protocol bolus feature and establishment of a low BG threshold for temporary interruption of infusion. Computer-guided dosing may improve target attainment without exacerbating risk for hypoglycemia. Column assignment (MR) within a tabular user-interpreted algorithm or multiplier may be specified initially according to patient characteristics and medical condition with revision during treatment based on patient response. We hypothesize that a strictly increasing sigmoidal relationship between MR-dependent IR and BG may reduce risk for hypoglycemia, in comparison to a linear relationship between multiplier-dependent IR and BG. Guidelines are needed that curb excessive up-titration of MR and recommend periodic pre-emptive trials of MR reduction. Future research should foster development of recommendations for "protocol maxima" of IR appropriate to patient condition.

Entities:  

Keywords:  Best practices; Critical care; Critical care protocols; Hypoglycemia; Insulin infusion; Insulin protocol

Mesh:

Substances:

Year:  2018        PMID: 29582176     DOI: 10.1007/s11892-018-0994-4

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  87 in total

1.  Stochastic targeted (STAR) glycemic control: design, safety, and performance.

Authors:  Alicia Evans; Aaron Le Compte; Chia-Siong Tan; Logan Ward; James Steel; Christopher G Pretty; Sophie Penning; Fatanah Suhaimi; Geoffrey M Shaw; Thomas Desaive; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 2.  A detailed description of the implementation of inpatient insulin orders with a commercial electronic health record system.

Authors:  Aaron Neinstein; Heidemarie Windham MacMaster; Mary M Sullivan; Robert Rushakoff
Journal:  J Diabetes Sci Technol       Date:  2014-05-25

3.  Performance of a dose-defining insulin infusion protocol among trauma service intensive care unit admissions.

Authors:  Susan S Braithwaite; Renee Edkins; Kathy L Macgregor; Edward S Sredzienski; Michael Houston; Ben Zarzaur; Preston B Rich; Bernard Benedetto; Edmund J Rutherford
Journal:  Diabetes Technol Ther       Date:  2006-08       Impact factor: 6.118

Review 4.  Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2016-11-21       Impact factor: 19.112

Review 5.  Glucose Control in the ICU: A Continuing Story.

Authors:  Jean-Charles Preiser; J Geoffrey Chase; Roman Hovorka; Jeffrey I Joseph; James S Krinsley; Christophe De Block; Thomas Desaive; Luc Foubert; Pierre Kalfon; Ulrike Pielmeier; Tom Van Herpe; Jan Wernerman
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

6.  A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms.

Authors:  Christopher A Newton; Dawn Smiley; Bruce W Bode; Abbas E Kitabchi; Paul C Davidson; Sol Jacobs; R Dennis Steed; Frankie Stentz; Limin Peng; Patrick Mulligan; Amado X Freire; Angel Temponi; Guillermo E Umpierrez
Journal:  J Hosp Med       Date:  2010-10       Impact factor: 2.960

7.  Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit.

Authors:  Philip A Goldberg; Mark D Siegel; Robert S Sherwin; Joshua I Halickman; Michelle Lee; Valerie A Bailey; Sandy L Lee; James D Dziura; Silvio E Inzucchi
Journal:  Diabetes Care       Date:  2004-02       Impact factor: 19.112

8.  Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic control.

Authors:  Christopher G Pretty; Aaron J Le Compte; J Geoffrey Chase; Geoffrey M Shaw; Jean-Charles Preiser; Sophie Penning; Thomas Desaive
Journal:  Ann Intensive Care       Date:  2012-06-15       Impact factor: 6.925

9.  Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control.

Authors:  Alicia Evans; Geoffrey M Shaw; Aaron Le Compte; Chia-Siong Tan; Logan Ward; James Steel; Christopher G Pretty; Leesa Pfeifer; Sophie Penning; Fatanah Suhaimi; Matthew Signal; Thomas Desaive; J Geoffrey Chase
Journal:  Ann Intensive Care       Date:  2011-09-19       Impact factor: 6.925

10.  Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis.

Authors:  Kent W Stewart; Christopher G Pretty; Hamish Tomlinson; Felicity L Thomas; József Homlok; Szabó Némedi Noémi; Attila Illyés; Geoffrey M Shaw; Balázs Benyó; J Geoffrey Chase
Journal:  Ann Intensive Care       Date:  2016-03-29       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.